Invesco’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.81B | Buy |
25,138,946
+1,119,805
| +5% | +$86.3M | 0.18% | 95 |
|
|
2025
Q4 | $1.91B | Sell |
24,019,141
-273,917
| -1% | -$21.6M | 0.18% | 92 |
|
|
2025
Q3 | $1.83B | Buy |
24,293,058
+760,579
| +3% | +$52.1M | 0.29% | 43 |
|
|
2025
Q2 | $1.62B | Buy |
23,532,479
+3,118,626
| +15% | +$204M | 0.28% | 48 |
|
|
2025
Q1 | $1.38B | Buy |
20,413,853
+2,375,764
| +13% | +$142M | 0.26% | 55 |
|
|
2024
Q4 | $810M | Buy |
18,038,089
+4,173,243
| +30% | +$234M | 0.15% | 135 |
|
|
2024
Q3 | $872M | Buy |
13,864,846
+1,774,453
| +15% | +$104M | 0.17% | 120 |
|
|
2024
Q2 | $714M | Sell |
12,090,393
-2,546,382
| -17% | -$159M | 0.15% | 136 |
|
|
2024
Q1 | $1.17B | Sell |
14,636,775
-1,323,283
| -8% | -$101M | 0.25% | 61 |
|
|
2023
Q4 | $1.26B | Sell |
15,960,058
-135,832
| -0.8% | -$9.67M | 0.3% | 44 |
|
|
2023
Q3 | $1.12B | Sell |
16,095,890
-906,597
| -5% | -$64.2M | 0.3% | 40 |
|
|
2023
Q2 | $1.18B | Buy |
17,002,487
+1,605,878
| +10% | +$114M | 0.31% | 41 |
|
|
2023
Q1 | $1.14B | Sell |
15,396,609
-279,629
| -2% | -$23.4M | 0.32% | 42 |
|
|
2022
Q4 | $1.46B | Sell |
15,676,238
-1,473,754
| -9% | -$142M | 0.43% | 22 |
|
|
2022
Q3 | $1.64B | Buy |
17,149,992
+393,212
| +2% | +$38.9M | 0.53% | 15 |
|
|
2022
Q2 | $1.55B | Sell |
16,756,780
-576,761
| -3% | -$56.3M | 0.47% | 21 |
|
|
2022
Q1 | $1.75B | Sell |
17,333,541
-358,250
| -2% | -$37.6M | 0.45% | 21 |
|
|
2021
Q4 | $1.83B | Sell |
17,691,791
-319,776
| -2% | -$29.5M | 0.44% | 25 |
|
|
2021
Q3 | $1.53B | Buy |
18,011,567
+4,645,402
| +35% | +$389M | 0.39% | 34 |
|
|
2021
Q2 | $1.12B | Buy |
13,366,165
+190,018
| +1% | +$15.6M | 0.27% | 51 |
|
|
2021
Q1 | $991M | Buy |
13,176,147
+304,146
| +2% | +$22.2M | 0.26% | 57 |
|
|
2020
Q4 | $879M | Buy |
12,872,001
+2,535,317
| +25% | +$165M | 0.26% | 67 |
|
|
2020
Q3 | $604M | Sell |
10,336,684
-592,849
| -5% | -$36.9M | 0.2% | 98 |
|
|
2020
Q2 | $710M | Buy |
10,929,533
+643,745
| +6% | +$40.5M | 0.25% | 79 |
|
|
2020
Q1 | $610M | Sell |
10,285,788
-1,287,468
| -11% | -$85.9M | 0.26% | 82 |
|
|
2019
Q4 | $860M | Sell |
11,573,256
-524,092
| -4% | -$36.8M | 0.27% | 70 |
|
|
2019
Q3 | $763M | Buy |
12,097,348
+888,655
| +8% | +$52.7M | 0.2% | 100 |
|
|
2019
Q2 | $611M | Buy |
11,208,693
+638,593
| +6% | +$34.4M | 0.16% | 139 |
|
|
2019
Q1 | $570M | Sell |
10,570,100
-2,319,211
| -18% | -$143M | 0.19% | 116 |
|
|
2018
Q4 | $845M | Sell |
12,889,311
-253,465
| -2% | -$18.9M | 0.32% | 54 |
|
|
2018
Q3 | $1.03B | Buy |
13,142,776
+628,294
| +5% | +$44.9M | 0.33% | 54 |
|
|
2018
Q2 | $805M | Buy |
12,514,482
+2,000,042
| +19% | +$132M | 0.27% | 71 |
|
|
2018
Q1 | $654M | Buy |
10,514,440
+859,754
| +9% | +$61.7M | 0.24% | 85 |
|
|
2017
Q4 | $700M | Buy |
9,654,686
+2,482,593
| +35% | +$180M | 0.25% | 81 |
|
|
2017
Q3 | $583M | Buy |
7,172,093
+335,334
| +5% | +$26.5M | 0.22% | 102 |
|
|
2017
Q2 | $550M | Buy |
6,836,759
+3,426,341
| +100% | +$271M | 0.17% | 127 |
|
|
2017
Q1 | $268M | Sell |
3,410,418
-1,154,003
| -25% | -$92.1M | 0.09% | 248 |
|
|
2016
Q4 | $360M | Buy |
4,564,421
+547,737
| +14% | +$44.3M | 0.12% | 183 |
|
|
2016
Q3 | $357M | Buy |
4,016,684
+584,723
| +17% | +$55.2M | 0.12% | 189 |
|
|
2016
Q2 | $329M | Sell |
3,431,961
-559,962
| -14% | -$55.8M | 0.12% | 188 |
|
|
2016
Q1 | $414M | Sell |
3,991,923
-610,735
| -13% | -$59.4M | 0.17% | 139 |
|
|
2015
Q4 | $450M | Sell |
4,602,658
-1,214,517
| -21% | -$119M | 0.18% | 117 |
|
|
2015
Q3 | $561M | Sell |
5,817,175
-62,678
| -1% | -$6.59M | 0.24% | 85 |
|
|
2015
Q2 | $617M | Buy |
5,879,853
+1,201,552
| +26% | +$123M | 0.24% | 83 |
|
|
2015
Q1 | $483M | Sell |
4,678,301
-1,052,779
| -18% | -$107M | 0.19% | 116 |
|
|
2014
Q4 | $552M | Sell |
5,731,080
-2,751,488
| -32% | -$242M | 0.21% | 103 |
|
|
2014
Q3 | $675M | Buy |
8,482,568
+388,519
| +5% | +$30.6M | 0.27% | 69 |
|
|
2014
Q2 | $610M | Sell |
8,094,049
-162,411
| -2% | -$12.3M | 0.24% | 82 |
|
|
2014
Q1 | $618M | Sell |
8,256,460
-1,135,102
| -12% | -$80.2M | 0.25% | 74 |
|
|
2013
Q4 | $672M | Buy |
9,391,562
+36,009
| +0.4% | +$2.31M | 0.27% | 69 |
|
|
2013
Q3 | $531M | Sell |
9,355,553
-263,542
| -3% | -$15.7M | 0.23% | 90 |
|
|
2013
Q2 | $550M | Buy |
+9,619,095
| New | +$557M | 0.26% | 81 |
|
Other funds holding CVS
VCM
VPM
Invesco's CVS Position: Q1 2026 in Review
Invesco increased its CVS Health (CVS) stake by 4.7% in Q1 2026, buying an estimated $86.3M and bringing the position to 25,138,946 shares worth $1.81B. The position accounts for 0.18% of the portfolio, ranked #95.
Invesco first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.91B in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Invesco held 25,138,946 shares of CVS Health worth $1.81B as of Q1 2026.
- Invesco bought 1,119,805 CVS Health shares in Q1 2026, an estimated $86.3M.
- CVS Health made up 0.18% of Invesco's portfolio in Q1 2026, its #95 holding.
- Invesco first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Invesco's CVS Health position peaked at $1.91B in Q4 2025.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.